Filing Details
- Accession Number:
- 0001209191-21-050631
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-08-10 16:55:05
- Reporting Period:
- 2021-08-06
- Accepted Time:
- 2021-08-10 16:55:05
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1819790 | Tarsus Pharmaceuticals Inc. | TARS | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1791249 | Michael Ackermann | C/O Tarsus Pharmaceuticals, Inc. 15440 Laguna Canyon Road, Suite 160 Irvine CA 92618 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2021-08-06 | 3,129 | $25.00 | 1,228,669 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-08-09 | 700 | $25.00 | 1,227,969 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 13, 2021.
Billionaire Hedge Funds
